Understanding malaria patterns and resistance in Burkina Faso
Burkina Faso ICEMR
['FUNDING_OTHER'] · COLORADO STATE UNIVERSITY · NIH-11386449
This project maps where and how malaria affects people and how parasites and mosquitoes respond to drugs and insecticides across different parts of Burkina Faso.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | COLORADO STATE UNIVERSITY (nih funded) |
| Locations | 1 site (FORT COLLINS, UNITED STATES) |
| Trial ID | NIH-11386449 on ClinicalTrials.gov |
What this research studies
From a patient perspective, local teams will collect basic clinical information and blood samples from people of different ages and link those to detailed studies of mosquitoes near homes, towns, and migrant/gold-mining camps. Labs will examine which parasite species are present, their genetics, and whether they show drug resistance, while entomologists study which mosquito species transmit malaria and whether they resist insecticides. Data will be centrally managed and shared with Burkinabé partners to strengthen local diagnosis, treatment, and prevention efforts. The project also aims to build local research and public-health capacity so communities can better track and respond to changing malaria patterns.
Who could benefit from this research
Good fit: Ideal participants are people living in malaria-affected areas of Burkina Faso—children and adults in urban neighborhoods, rural villages, and mobile or gold-mining camps—who can provide clinical information and blood samples.
Not a fit: People who do not live in or travel to malaria transmission areas of Burkina Faso are unlikely to receive direct benefit from this project.
Why it matters
Potential benefit: If successful, this work could lead to more targeted treatments and mosquito-control measures that better protect communities in Burkina Faso.
How similar studies have performed: Previous ICEMR and regional malaria studies have improved understanding of transmission and resistance patterns, though local findings and new resistance threats can still be unpredictable.
Where this research is happening
FORT COLLINS, UNITED STATES
- COLORADO STATE UNIVERSITY — FORT COLLINS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FOY, BRIAN DAVID — COLORADO STATE UNIVERSITY
- Study coordinator: FOY, BRIAN DAVID
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.